Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-001073
Filing Date
2024-02-20
Accepted
2024-02-20 12:27:29
Documents
60
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR 12-31-23 dh_i10q-123123.htm   iXBRL 10-Q 681383
2 CERTIFICATION dh_ex3101.htm EX-31.1 7652
3 CERTIFICATION dh_ex3201.htm EX-32.1 3691
4 GRAPHIC image_001.jpg GRAPHIC 3220
  Complete submission text file 0001683168-24-001073.txt   3553620

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE enmi-20231231.xsd EX-101.SCH 31056
6 XBRL CALCULATION FILE enmi-20231231_cal.xml EX-101.CAL 40215
7 XBRL DEFINITION FILE enmi-20231231_def.xml EX-101.DEF 109984
8 XBRL LABEL FILE enmi-20231231_lab.xml EX-101.LAB 202255
9 XBRL PRESENTATION FILE enmi-20231231_pre.xml EX-101.PRE 180537
61 EXTRACTED XBRL INSTANCE DOCUMENT dh_i10q-123123_htm.xml XML 499361
Mailing Address 6228 DARTLE STREET LAS VEGAS NV 89130
Business Address 6228 DARTLE STREET LAS VEGAS NV 89130 800-991-8697
DH ENCHANTMENT, INC. (Filer) CIK: 0001300781 (see all company filings)

EIN.: 201415044 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-56322 | Film No.: 24651781
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)